OPC Pharmaceutical Joint Stock Company Sustainability Profile
OPC Pharmaceutical Joint Stock Company, commonly referred to as OPC Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1976, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, primarily focusing on prescription medications and over-the-counter solutions. With a strong operational presence across various regions in Vietnam, OPC Pharma is renowned for its commitment to innovation and quality. The company offers a diverse range of core products, including generic drugs and herbal medicines, distinguished by their efficacy and safety. OPC Pharma's dedication to research and development has positioned it as a leader in the Vietnamese market, earning accolades for its contributions to healthcare and patient well-being.
DitchCarbon Score
How does OPC Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OPC Pharmaceutical Joint Stock Company's score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OPC Pharmaceutical Joint Stock Company's reported carbon emissions
OPC Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, OPC Pharmaceutical's climate commitments remain unclear, and there is no information available regarding their strategies for addressing carbon emissions or their overall environmental impact. The company does not inherit emissions data from any parent or related organizations, indicating that it operates independently in this regard. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and set measurable targets to reduce their carbon footprint. However, without specific data or commitments, it is challenging to assess OPC Pharmaceutical's position in this evolving landscape.
How Carbon Intensive is OPC Pharmaceutical Joint Stock Company's Industry?
How Carbon Intensive is OPC Pharmaceutical Joint Stock Company's Location?
OPC Pharmaceutical Joint Stock Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OPC Pharmaceutical Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
